Trial intelligence / Profile preview

Intra-arterial Ictal SPECT for Refractory Focal Epilepsy

NCT02513992Withdrawn

Sponsor
UZ Leuven
Start
May 2016
Primary completion
Jul 2018
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by UZ Leuven. Primary endpoint: Correct localization of the ictal onset zone. Planned start May 2016; status: withdrawn.

Beyond the preview

Go deeper on NCT02513992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02513992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call